Evidence map›Paper›PMID 34245452›Full record

ArticleJournal of medical virology2021

Updated SARS-CoV-2 single nucleotide variants and mortality association.

Shuyi Fang, Sheng Liu, Jikui Shen, Alex Z Lu, Audrey K Y Wang, Yucheng Zhang, Kailing Li, Juli Liu, Lei Yang, Chang-Deng Hu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2022
    Article
  11. Article
  12. The challenge of emerging SARS-CoV-2 mutants to vaccine development.Journal of genetics and genomics = Yi chuan xue bao · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Shuyi FangDepartment of BioHealth Informatics, Indiana University School of Informatics and Computing, Indiana University - Purdue University Indianapolis, Indianapolis, Indiana, USA.
Sheng LiuDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Jikui ShenThe Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alex Z LuPark Tudor School, Indianapolis, Indiana, USA.
Audrey K Y WangPark Tudor School, Indianapolis, Indiana, USA.
Yucheng ZhangDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kailing LiDepartment of BioHealth Informatics, Indiana University School of Informatics and Computing, Indiana University - Purdue University Indianapolis, Indianapolis, Indiana, USA.
Juli LiuDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Lei YangDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Chang-Deng HuDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana, USA.
Jun WanDepartment of BioHealth Informatics, Indiana University School of Informatics and Computing, Indiana University - Purdue University Indianapolis, Indianapolis, Indiana, USA.ORCID 0000-0001-9286-6562
Indiana University Health · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineTudor Place · USJohns Hopkins University · USPurdue University West Lafayette · US

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Jun Wan · 1999 to 2026
$59.3M
Indiana UniversityNCI NIH HHS P30 CA082709NIH
6 · The paper itself

Abstract

By analyzing newly collected SARS-CoV-2 genomes and comparing them with our previous study about SARS-CoV-2 single nucleotide variants (SNVs) before June 2020, we found that the SNV clustering had changed remarkably since June 2020. Apart from that the group of SNVs became dominant, which is represented by two nonsynonymous mutations A23403G (S:D614G) and C14408T (ORF1ab:P4715L), a few emerging groups of SNVs were recognized with sharply increased monthly incidence ratios of up to 70% in November 2020. Further investigation revealed sets of SNVs specific to patients' ages and/or gender, or strongly associated with mortality. Our logistic regression model explored features contributing to mortality status, including three critical SNVs, G25088T(S:V1176F), T27484C (ORF7a:L31L), and T25A (upstream of ORF1ab), ages above 40 years old, and the male gender. The protein structure analysis indicated that the emerging subgroups of nonsynonymous SNVs and the mortality-related ones were located on the protein surface area. The clashes in protein structure introduced by these mutations might in turn affect the viral pathogenesis through the alteration of protein conformation, leading to a difference in transmission and virulence. Particularly, we explored the fact that nonsynonymous SNVs tended to occur in intrinsic disordered regions of Spike and ORF1ab to significantly increase hydrophobicity, suggesting a potential role in the change of protein folding related to immune evasion.

Indexed as

AdultAgedAged, 80 and overCOVID-19FemaleGenome, ViralHumansMaleMiddle AgedMutationPolymorphism, Single NucleotidePolyproteinsSARS-CoV-2Spike Glycoprotein, CoronavirusViral ProteinsVirulenceORF1ab polyprotein, SARS-CoV-2PolyproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral Proteinsagegendermortality risk factorSARS-CoV-2single nucleotide variants

Identifiers

PMID34245452
PMCPMC8426680
OpenAlexW3181473869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.